[Pubmed] Two-decade battle with myasthenia gravis: A breakthrough case report on the long-term success with eculizumab a
Posté : 06 nov. 2024 12:00
Clin Case Rep. 2024 Nov 4;12(11):e9547. doi: 10.1002/ccr3.9547. eCollection 2024 Nov.
ABSTRACT
This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease. It highlights the long-term effectiveness of C5 inhibitors in a real-world setting, aiding physicians in their decision-making for refractory cases and treatment discontinuation scenarios.
PMID:39502126 | PMC:PMC11534635 | DOI:10.1002/ccr3.9547
Source: https://pubmed.ncbi.nlm.nih.gov/3950212 ... t9+e462414